• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

植入式心脏除颤器患者的室性心律失常鉴别器编程及其对不适当治疗发生率的影响。

Ventricular arrhythmia discriminator programming and the impact on the incidence of inappropriate therapy in patients with implantable cardiac defibrillators.

作者信息

Srivatsa Uma N, Hoppe Bobbi L, Narayan Sanjiv, Feld Gregory K, Birgersdotter-Green Ulrika

机构信息

UCSD Medical Center, and the Veterans Administration Medical Center, San Diego, CA, USA.

出版信息

Indian Pacing Electrophysiol J. 2007 Apr 1;7(2):77-84.

PMID:17538699
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1877826/
Abstract

BACKGROUND

The incidence of inappropriate therapy from implantable cardioverter defibrillators (ICDs) has been reduced by programming ventricular arrhythmia discriminators (VAD) on at the time of implant.

OBJECTIVE

To determine which VAD is most effective in preventing inappropriate therapy.

METHODS AND RESULTS

Dual chamber ICD (n=48) or cardiac resynchronization therapy defibrillator (CRT-D) (n=55) implantation was performed in 103 patients (M=94, F=9). Patients were followed prospectively for therapy events (shock or anti-tachycardia pacing) for a mean 362+/-289 days. Events were correlated with clinical characteristics and VAD programming. Of the 103 pts followed, 11 received inappropriate therapy (IT), 15 received appropriate therapy (AT), and 77 received no therapy (NT). In the AT and IT groups, a total of 207 events (ATP=171, shock=36) were observed. A total of sixty-four electrograms (EGMs) were analyzed. Programming VADs "ON" versus "OFF" reduced the incidence of IT events compared to those receiving AT or NT events (p<.01), with a trend in fewer patients receiving IT (31.3% "ON" vs 55.6% "OFF", p = 0.131). Programming atrial fibrillation (AF) detection ON resulted in fewer patients receiving IT compared to those receiving AT or NT (3.6% vs 19%, p<.05). Furthermore, programming AF or AFL algorithms "ON", resulted in overall fewer episodes of IT therapy (p<.01).

CONCLUSION

AF or AFL discriminators significantly reduced the incidence of IT, and were predominantly responsible for the benefits from VAD programming observed in this study. Activating these features as part of routine ICD or CRT-D programming may provide a simple and effective alternative to the use of more complex and multiple VAD strategies.

摘要

背景

通过在植入时对室性心律失常鉴别器(VAD)进行编程,植入式心脏复律除颤器(ICD)不适当治疗的发生率已有所降低。

目的

确定哪种VAD在预防不适当治疗方面最有效。

方法与结果

对103例患者(男性94例,女性9例)进行了双腔ICD(n = 48)或心脏再同步治疗除颤器(CRT-D)(n = 55)植入。对患者进行前瞻性随访,观察治疗事件(电击或抗心动过速起搏),平均随访时间为362±289天。将事件与临床特征和VAD编程相关联。在随访的103例患者中,11例接受了不适当治疗(IT),15例接受了适当治疗(AT),77例未接受治疗(NT)。在AT组和IT组中,共观察到207次事件(ATP = 171次,电击 = 36次)。共分析了64份心电图(EGM)。与接受AT或NT事件的患者相比,将VAD编程为“开启”与“关闭”可降低IT事件的发生率(p <.01),接受IT治疗的患者数量有减少趋势(“开启”组为31.3%,“关闭”组为55.6%,p = 0.131)。与接受AT或NT治疗的患者相比,将房颤(AF)检测编程为开启可使接受IT治疗的患者数量减少(3.6%对19%,p <.05)。此外,将AF或AFL算法编程为“开启”可使IT治疗的发作总数减少(p <.01)。

结论

AF或AFL鉴别器显著降低了IT的发生率,并且在本研究中观察到的VAD编程带来的益处主要归因于它们。作为常规ICD或CRT-D编程的一部分激活这些功能,可能为使用更复杂和多种VAD策略提供一种简单有效的替代方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11a7/1877826/18c984703e52/ipej070077-01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11a7/1877826/18c984703e52/ipej070077-01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/11a7/1877826/18c984703e52/ipej070077-01.jpg

相似文献

1
Ventricular arrhythmia discriminator programming and the impact on the incidence of inappropriate therapy in patients with implantable cardiac defibrillators.植入式心脏除颤器患者的室性心律失常鉴别器编程及其对不适当治疗发生率的影响。
Indian Pacing Electrophysiol J. 2007 Apr 1;7(2):77-84.
2
A prospective randomized trial of single- or dual-chamber implantable cardioverter-defibrillators to minimize inappropriate shock risk in primary sudden cardiac death prevention.前瞻性随机试验比较单腔和双腔植入式心脏复律除颤器,以降低一级预防心源性猝死时不必要电击的风险。
Europace. 2014 Oct;16(10):1460-8. doi: 10.1093/europace/euu022. Epub 2014 Jun 13.
3
Novel ICD Programming and Inappropriate ICD Therapy in CRT-D Versus ICD Patients: A MADIT-RIT Sub-Study.心脏再同步化治疗除颤器(CRT-D)与植入式心律转复除颤器(ICD)患者中新型 ICD 程控与不适当 ICD 治疗:MADIT-RIT 子研究。
Circ Arrhythm Electrophysiol. 2016 Jan;9(1):e001965. doi: 10.1161/CIRCEP.114.001965.
4
Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study.根据电击节律对植入式心脏复律除颤器和心脏再同步治疗除颤器受者电击治疗后的生存情况。节律研究中的 ALTITUDE 生存情况。
J Am Coll Cardiol. 2013 Oct 29;62(18):1674-1679. doi: 10.1016/j.jacc.2013.04.083. Epub 2013 Jun 27.
5
Low inappropriate shock rates in patients with single- and dual/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results.采用一套新型检测算法的单腔和双腔/三腔植入式心脏复律除颤器患者的低不适当电击率:无痛SST试验主要结果
Heart Rhythm. 2015 May;12(5):926-36. doi: 10.1016/j.hrthm.2015.01.017. Epub 2015 Jan 28.
6
The impact of atrial fibrillation with rapid ventricular rates and device programming on shocks in 106,513 ICD and CRT-D patients.快速心室率伴心房颤动及装置程控对 106513 例 ICD 和 CRT-D 患者电击的影响。
Heart Rhythm. 2012 Jan;9(1):24-31. doi: 10.1016/j.hrthm.2011.08.005. Epub 2011 Aug 9.
7
Prospective Randomized Evaluation of Implantable Cardioverter-Defibrillator Programming in Patients With a Left Ventricular Assist Device.前瞻性随机评估左心室辅助装置患者植入式心脏复律除颤器的程控。
J Am Heart Assoc. 2018 Feb 23;7(5):e007748. doi: 10.1161/JAHA.117.007748.
8
Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy).卡维地洛和美托洛尔对植入式心律转复除颤器不适当治疗的影响:MADIT-CRT 试验(心脏再同步治疗的多中心自动除颤器植入)。
J Am Coll Cardiol. 2013 Oct 8;62(15):1343-50. doi: 10.1016/j.jacc.2013.03.087. Epub 2013 Jun 13.
9
Programming antitachycardia pacing for primary prevention in patients with implantable cardioverter defibrillators: results from the PROVE trial.在植入式心律转复除颤器患者中进行原发性预防的抗心动过速起搏编程:来自 PROVE 试验的结果。
J Cardiovasc Electrophysiol. 2010 Dec;21(12):1349-54. doi: 10.1111/j.1540-8167.2010.01825.x.
10
Supraventricular arrhythmias in children and young adults with implantable cardioverter defibrillators.植入式心脏复律除颤器治疗的儿童和青年患者的室上性心律失常
J Cardiovasc Electrophysiol. 2001 Oct;12(10):1097-101. doi: 10.1046/j.1540-8167.2001.01097.x.

本文引用的文献

1
Randomized controlled study of detection enhancements versus rate-only detection to prevent inappropriate therapy in a dual-chamber implantable cardioverter-defibrillator.双腔植入式心脏复律除颤器中检测增强与仅速率检测预防不适当治疗的随机对照研究。
Heart Rhythm. 2004 Nov;1(5):540-7. doi: 10.1016/j.hrthm.2004.07.017.
2
Prevention of inappropriate therapy in implantable cardioverter-defibrillators: results of a prospective, randomized study of tachyarrhythmia detection algorithms.植入式心脏复律除颤器不适当治疗的预防:心动过速检测算法的前瞻性随机研究结果
J Am Coll Cardiol. 2004 Dec 21;44(12):2362-7. doi: 10.1016/j.jacc.2004.09.039.
3
High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator.植入式心脏复律除颤器在儿童和青少年中适当和不适当治疗的高发生率。
Pacing Clin Electrophysiol. 2004 Jul;27(7):924-32. doi: 10.1111/j.1540-8159.2004.00560.x.
4
The DATAS rationale and design: a controlled, randomized trial to assess the clinical benefit of dual chamber (DDED) defibrillator.DATAS的原理与设计:一项评估双腔(DDED)除颤器临床益处的对照随机试验。
Europace. 2004 Mar;6(2):142-50. doi: 10.1016/j.eupc.2003.11.011.
5
Increase in ventricular tachycardia frequency after biventricular implantable cardioverter defibrillator upgrade.双心室植入式心脏复律除颤器升级后室性心动过速频率增加。
J Cardiovasc Electrophysiol. 2003 Nov;14(11):1245-7. doi: 10.1046/j.1540-8167.2003.03303.x.
6
Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial.抗心律失常药物与植入式除颤器(AVID)试验中植入式心脏复律除颤器治疗的分析。
J Cardiovasc Electrophysiol. 2003 Sep;14(9):940-8. doi: 10.1046/j.1540-8167.2003.01554.x.
7
Efficacy of implantable cardioverter defibrillator therapy for primary and secondary prevention of sudden cardiac death in hypertrophic cardiomyopathy.植入式心脏复律除颤器治疗肥厚型心肌病心脏性猝死一级和二级预防的疗效
Pacing Clin Electrophysiol. 2003 Sep;26(9):1887-96. doi: 10.1046/j.1460-9592.2003.00285.x.
8
Is inappropriate implantable defibrillator shock therapy predictable?
J Interv Card Electrophysiol. 2003 Jun;8(3):215-20. doi: 10.1023/a:1023973306742.
9
Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.晚期慢性心力衰竭患者联合心脏再同步化治疗与植入式心脏复律除颤治疗:MIRACLE ICD试验
JAMA. 2003 May 28;289(20):2685-94. doi: 10.1001/jama.289.20.2685.
10
Adverse events with transvenous implantable cardioverter-defibrillators: a prospective multicenter study. European 7219 Jewel ICD investigators.
Circulation. 1998 Aug 18;98(7):663-70. doi: 10.1161/01.cir.98.7.663.